Lingjiao Wu
- Cancer Research top 10%
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
-
- Antibiotic Resistance in Bacteria 5
-
- Circular RNAs in diseases 3
-
- Cardiovascular Disease and Adiposity 2
-
- Ferroptosis and cancer prognosis 2
-
- Hormonal and reproductive studies 2
-
- Adipokines, Inflammation, and Metabolic Diseases 2
- Co-authors
- Fusheng WuQiangfeng WangZeran YangXiuming ZhuRong YangJie XuJian YaoBeiwen Zheng
- Journals
- SHILAP Revista de lepidopterología (1 paper)Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lingjiao Wu
27 papers receiving 606 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 237
- Molecular Medicine 31
- Molecular Biology 414
- Hepatology 37
- Infectious Diseases 62
Countries citing papers authored by Lingjiao Wu
This map shows the geographic impact of Lingjiao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjiao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjiao Wu more than expected).
Fields of papers citing papers by Lingjiao Wu
This network shows the impact of papers produced by Lingjiao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjiao Wu. The network helps show where Lingjiao Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingjiao Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 9 | |
| 7 | 2019 | 32 | |
| 8 | 2018 | 2 | |
| 9 | 2018 | 39 | |
| 10 | 2018 | 8 | |
| 11 | 2018 | 29 | |
| 12 | 2016 | 24 | |
| 13 | 2015 | 93 | |
| 14 | 2014 | 30 | |
| 15 | 2013 | 47 | |
| 16 | 2012 | 6 | |
| 17 | 2009 | 12 | |
| 18 | 2007 | 5 | |
| 19 | [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. | 2006 | 13 |
| 20 | 2005 | 28 |
About Lingjiao Wu
Lingjiao Wu is a scholar working on Molecular Medicine, Endocrinology and Cancer Research, having authored 31 papers that have together received 608 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Circular RNAs in diseases (3 papers), Cardiovascular Disease and Adiposity (2 papers), Ferroptosis and cancer prognosis (2 papers), Hormonal and reproductive studies (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Cancer Research (237 citations), Molecular Medicine (31 citations) and Molecular Biology (414 citations). Lingjiao Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fusheng Wu, Qiangfeng Wang, Zeran Yang, Xiuming Zhu, Rong Yang, Jie Xu, Jian Yao, Beiwen Zheng, Shusen Zheng and Guohong Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.